SARDU, Celestino
 Distribuzione geografica
Continente #
EU - Europa 4.918
AS - Asia 3.712
NA - Nord America 2.808
SA - Sud America 672
AF - Africa 57
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.176
Nazione #
US - Stati Uniti d'America 2.744
RU - Federazione Russa 1.804
SG - Singapore 1.259
IT - Italia 1.147
IE - Irlanda 866
CN - Cina 779
HK - Hong Kong 701
BR - Brasile 559
GB - Regno Unito 265
DE - Germania 264
KR - Corea 249
IN - India 234
VN - Vietnam 202
UA - Ucraina 118
FR - Francia 109
JP - Giappone 89
TR - Turchia 69
FI - Finlandia 64
GR - Grecia 53
SE - Svezia 44
AR - Argentina 36
NL - Olanda 35
AT - Austria 31
CA - Canada 27
MX - Messico 24
EC - Ecuador 22
CZ - Repubblica Ceca 21
DK - Danimarca 21
BE - Belgio 16
CO - Colombia 16
ID - Indonesia 16
PK - Pakistan 16
IR - Iran 14
ZA - Sudafrica 14
BD - Bangladesh 13
PY - Paraguay 12
IQ - Iraq 11
LT - Lituania 11
PL - Polonia 11
IL - Israele 10
SC - Seychelles 10
AU - Australia 8
EG - Egitto 8
ET - Etiopia 8
MA - Marocco 8
VE - Venezuela 8
KE - Kenya 7
PE - Perù 7
CL - Cile 6
ES - Italia 6
TW - Taiwan 6
UZ - Uzbekistan 6
PT - Portogallo 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
CH - Svizzera 4
JM - Giamaica 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
EE - Estonia 3
GE - Georgia 3
JO - Giordania 3
OM - Oman 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AN - Antille olandesi 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.176
Città #
Dublin 857
Hong Kong 693
Moscow 613
Singapore 506
Santa Clara 472
Chandler 304
Seoul 247
Naples 230
Jacksonville 215
Hefei 190
Bengaluru 187
Caserta 158
The Dalles 144
Dallas 134
Beijing 117
Princeton 103
Roxbury 95
Ashburn 91
New York 84
Munich 83
Ho Chi Minh City 79
Ann Arbor 75
Medford 68
Bremen 57
São Paulo 56
Wilmington 48
Aversa 46
Cambridge 36
Hanoi 36
Woodbridge 34
Los Angeles 32
Istanbul 31
Ercolano 30
Falkenstein 30
Milan 28
Napoli 27
Salerno 27
Des Moines 24
Amsterdam 23
Nuremberg 22
Brno 19
Juelsminde 19
Boardman 18
Nanjing 18
Turku 18
Boydton 16
Brooklyn 15
Brussels 15
Giugliano In Campania 15
Houston 14
Rome 14
Sarno 14
Vienna 14
Helsinki 13
Mountain View 13
Rio de Janeiro 13
Redwood City 12
San Mateo 12
Bari 11
Brasília 11
Düsseldorf 11
Lappeenranta 11
Tianjin 11
Frankfurt am Main 10
Guayaquil 10
Porto Alegre 10
Shanghai 10
Belo Horizonte 9
Biên Hòa 9
Castellammare di Stabia 9
Haiphong 9
Hyderabad 9
London 9
Paris 9
Toronto 9
Vitulazio 9
Warsaw 9
Addis Ababa 8
Atlanta 8
Campinas 8
Chennai 8
Curitiba 8
Guangzhou 8
Johannesburg 8
Chicago 7
Nonantola 7
Quito 7
Ribeirão Preto 7
Stockholm 7
Tokyo 7
Bologna 6
Buenos Aires 6
Da Nang 6
Hicksville 6
Jinan 6
Lahore 6
Manchester 6
Mcallen 6
Montreal 6
Mumbai 6
Totale 6.947
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 249
Abdominal fat SIRT6 expression and its relationship with inflammatory and metabolic pathways in pre-diabetic overweight patients 176
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 150
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 147
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders 136
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment 135
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 128
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients 124
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 124
123I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy. 123
Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study 123
Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: Relationship with cardiac performance in overweight pre-diabetics patients 121
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage 120
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin 118
Awaking blood pressure surge and progression to microalbuminuria in type 2 normotensive diabetic patients 115
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 108
Molecular mechanisms and therapeutic targets of inflammatory-related Cardiovascular diseases: from molecular mechanisms to therapeutic targets 108
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 106
Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation. 105
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 105
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 104
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 104
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 102
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells 100
Hyperglycaemia on admission to hospital and COVID-19 100
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts 100
Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients 99
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 98
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? 97
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 96
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 95
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 94
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 94
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest 93
null 93
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 92
Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation. 92
Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome 92
Cardiovascular benefits from gliflozins: Effects on endothelial function 91
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 91
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 90
Functional role of miRNA in cardiac resynchronization therapy. 89
Atherosclerotic plaque fissuration and clinical outcomes in pre-diabetics vs. normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of follow-up: Role of micrornas modulation: The atimir study 89
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 89
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 88
MRI in Pregnancy and Precision Medicine: A Review from Literature 88
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy 87
DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study 87
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 86
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 86
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 84
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 84
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 84
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 83
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes. 82
[HIV and related infections in Italian penal institutions: epidemiological and health organization note] 81
NT-proBNP, IGF-I and survival in patients with chronic heart failure 81
Implications of AB0 blood group in hypertensive patients with covid-19 81
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 81
Author's reply 80
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 79
Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes 79
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: Clinical outcomes at 1-year follow-up 78
Effects of metformin therapy on COronary endothelial DYsfunction in prediabetic patients With stable angina and Non Obstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study. 78
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 77
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells 76
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 75
Cardiac biomarkers predict 1-year mortality in elderly patients undergoing hip fracture surgery 75
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 75
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 74
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study 74
Calcium release channel RyR2 regulates insulin release and glucose homeostasis 73
Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease 73
The dating of thrombus organization in cases of pulmonary embolism: An autopsy study 73
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 73
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry 72
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 71
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 71
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy 71
Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence 71
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction 71
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 71
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 71
Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy 70
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up (vol 17, pg 512, 2018) 69
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes 68
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 68
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence 68
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 67
Letter by Sardu et al Regarding Article, "circulating MicroRNA-30d Is Associated with Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study" 66
COVID-19 and Endothelial Dysfunction 66
Evidence for human diabetic cardiomyopathy. 66
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 65
Automated 3D Ultrasound as an Adjunct to Screening Mammography Programs in Dense Breast: Literature Review and Metanalysis 65
Impact of Sex Differences in Incident and Recurrent Coronary Events and All-Cause Mortality 65
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 65
Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac Arrest. 64
MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo 64
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 63
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 63
Totale 9.071
Categoria #
all - tutte 53.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.197


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021335 0 0 0 0 0 37 70 44 40 35 95 14
2021/2022841 25 7 44 26 208 14 41 34 44 71 82 245
2022/20231.489 125 53 41 64 182 84 23 70 768 24 25 30
2023/2024921 58 58 40 50 243 106 20 18 17 49 89 173
2024/20253.003 40 50 30 103 381 349 445 294 368 460 242 241
2025/20264.847 569 784 677 559 936 1.322 0 0 0 0 0 0
Totale 12.552